Silverarc Capital Management

Latest statistics and disclosures from Silverarc Capital Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Silverarc Capital Management

Companies in the Silverarc Capital Management portfolio as of the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Vericel (VCEL) 5.0 $8.7M 281k 30.88
Biogen Call Call Option 4.3 $7.3M 30k 244.87
Intra Cellular Therapies (ITCI) 3.7 $6.4M 200k 31.80
Delcath Sys Com New (DCTH) 3.7 $6.3M 352k 17.92
Insmed Com Par $.01 (INSM) 3.4 $5.8M 175k 33.29
Amryt Pharma Sponsored Ads (AMYT) 3.3 $5.7M 403k 14.16
Dicerna Pharmaceuticals (DRNA) 2.9 $5.0M 227k 22.03
Arvinas Ord (ARVN) 2.7 $4.7M 55k 84.93
Larimar Therapeutics (LRMR) 2.7 $4.6M 217k 21.41
Immunovant (IMVT) 2.7 $4.6M 100k 46.19
Mirati Therapeutics (MRTX) 2.6 $4.4M 20k 219.65
Curis Com New (CRIS) 2.5 $4.3M 530k 8.19
Halozyme Therapeutics (HALO) 2.5 $4.3M 100k 42.71
Tcr2 Therapeutics Inc cs (TCRR) 2.4 $4.2M 136k 30.93

Setup an alert

Silverarc Capital Management will file the next quarterly 13-HR in about 1 months. Would you like to be notified?

Sutro Biopharma (STRO) 2.3 $4.0M 185k 21.71
ImmunoGen (IMGN) 2.2 $3.9M 600k 6.45
Essa Pharma Com New (EPIX) 2.2 $3.9M 323k 11.93
Cellectar Biosciences Com Par (CLRB) 2.1 $3.7M 1.8M 2.08
Chemocentryx (CCXI) 1.9 $3.3M 54k 61.92
Kura Oncology (KURA) 1.7 $2.9M 90k 32.66
Ascendis Pharma A/s Sponsored Adr (ASND) 1.7 $2.9M 18k 166.78
Jounce Therapeutics (JNCE) 1.7 $2.8M 407k 7.00
Evogene SHS (EVGN) 1.6 $2.8M 600k 4.70
Cogent Biosciences (COGT) 1.5 $2.6M 235k 11.23
Helix Acquisition Corp Com Cl A (HLXA) 1.4 $2.4M 215k 11.37
Guardant Health (GH) 1.4 $2.4M 19k 128.87
Verastem (VSTM) 1.4 $2.4M 1.1M 2.13
Affimed Therapeutics B V (AFMD) 1.4 $2.3M 400k 5.82
Renalytix Ai Ads (RNLX) 1.3 $2.3M 141k 16.00
Deciphera Pharmaceuticals (DCPH) 1.3 $2.2M 39k 57.07
Horizon Therapeutics Pub L SHS (HZNP) 1.3 $2.2M 30k 73.17
Sierra Oncology Com New (SRRA) 1.3 $2.2M 135k 16.03
Turning Point Therapeutics I (TPTX) 1.1 $2.0M 16k 121.88
Adamas Pharmaceuticals (ADMS) 1.1 $1.9M 441k 4.33
Compugen Ord (CGEN) 1.1 $1.8M 151k 12.11
Morphic Hldg (MORF) 1.0 $1.7M 51k 33.56
Otonomy (OTIC) 1.0 $1.7M 264k 6.47
Trillium Therapeutics Com New (TRIL) 0.9 $1.6M 110k 14.71
Arena Pharmaceuticals Com New (ARNA) 0.9 $1.5M 20k 76.85
Zymeworks (ZYME) 0.8 $1.5M 31k 47.25
Nextcure (NXTC) 0.8 $1.4M 130k 10.90
Biohaven Pharmaceutical Holding (BHVN) 0.8 $1.4M 17k 85.70
Celldex Therapeutics Com New (CLDX) 0.8 $1.4M 80k 17.53
Seagen (SGEN) 0.8 $1.3M 7.5k 175.12
Scholar Rock Hldg Corp (SRRK) 0.7 $1.2M 25k 48.52
Surface Oncology (SURF) 0.7 $1.2M 130k 9.24
Vertex Pharmaceuticals Incorporated (VRTX) 0.7 $1.2M 5.0k 236.40
89bio (ETNB) 0.6 $1.1M 44k 24.36
Kadmon Hldgs (KDMN) 0.6 $1.0M 242k 4.15
Mereo Biopharma Group Ads (MREO) 0.6 $1.0M 280k 3.58
Nkarta (NKTX) 0.5 $922k 15k 61.47
Akero Therapeutics (AKRO) 0.5 $908k 35k 25.81
Iveric Bio (ISEE) 0.5 $899k 130k 6.91
BioCryst Pharmaceuticals (BCRX) 0.5 $820k 110k 7.45
United Therapeutics Corporation (UTHR) 0.5 $814k 5.4k 151.75
Alexion Pharmaceuticals (ALXN) 0.5 $781k 5.0k 156.20
Ardelyx (ARDX) 0.5 $776k 120k 6.47
Calithera Biosciences Call Call Option 0.4 $737k 150k 4.91
Biogen Idec (BIIB) 0.4 $735k 3.0k 245.00
Constellation Pharmceticls I (CNST) 0.4 $726k 25k 28.81
Actinium Pharmaceuticals (ATNM) 0.4 $702k 90k 7.80
Kala Pharmaceuticals (KALA) 0.4 $693k 102k 6.78
Syndax Pharmaceuticals (SNDX) 0.4 $667k 30k 22.23
EXACT Sciences Corporation (EXAS) 0.4 $662k 5.0k 132.40
Soleno Therapeutics Com New (SLNO) 0.4 $623k 323k 1.93
Leap Therapeutics (LPTX) 0.4 $619k 275k 2.25
Seres Therapeutics (MCRB) 0.4 $613k 25k 24.52
Gamida Cell SHS (GMDA) 0.3 $594k 71k 8.38
Vyne Therapeutics Com New 0.3 $552k 350k 1.58
Rocket Pharmaceuticals (RCKT) 0.3 $548k 10k 54.80
Therapeutics Acquisition Cor Com Cl A (RACA) 0.3 $543k 39k 13.92
Zentalis Pharmaceuticals (ZNTL) 0.3 $519k 10k 51.90
Medicenna Therapeutics Corp. (MDNA) 0.3 $503k 108k 4.68
Iovance Biotherapeutics (IOVA) 0.3 $464k 10k 46.40
Protagonist Therapeutics (PTGX) 0.2 $422k 21k 20.18
Aptinyx (APTX) 0.2 $372k 108k 3.46
Mersana Therapeutics (MRSN) 0.2 $286k 11k 26.57
Compugen Call Call Option 0.1 $242k 20k 12.10
Arcutis Biotherapeutics (ARQT) 0.1 $239k 8.5k 28.10
Fulcrum Therapeutics (FULC) 0.1 $190k 16k 11.72
Chardan Healthcare Acqu- Ord (PHGE) 0.1 $88k 14k 6.40
Calithera Biosciences (CALA) 0.0 $74k 15k 4.93
Chardan Healthcr Acqstn 2 *w Exp 03/05/202 (CHAQ.WS) 0.0 $49k 99k 0.50
Bionano Genomics *w Exp 08/21/202 (BNGOW) 0.0 $21k 10k 2.10

Past Filings by Silverarc Capital Management

SEC 13F filings are viewable for Silverarc Capital Management going back to 2020